Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|July 10, 2016
Don't Do Different Things…Do Things Differently! Drug Development in Rare DiseasesM A Rudek, J M Korth-BradleyClinical Pharmacology and Therapeutics|January 21, 2014
Pharmacotherapy in cancer patients with HIV/AIDSJ H Beumer, R Venkataramanan, M A RudekJournal of Pharmaceutical and Biomedical Analysis|June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasmaM A Rudek, C L March, K S Bauer, et al.Biomedical Chromatography : BMC|August 29, 2000
A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and salivaK S Bauer, R M Lush, M A Rudek, et al.American Journal of Hematology|April 3, 2001
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3M A Rudek, M Horne, W D Figg, et al.British Journal of Cancer|December 3, 2011
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumoursR Pili, B Salumbides, M Zhao, et al.European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapyM A Rudek, A Sparreboom, E S Garrett-Mayer, et al.Archives of Dermatology|May 1, 2001
Drug-induced lupus associated with COL-3: report of 3 casesJ V Ghate, M L Turner, M A Rudek, et al.Prostate Cancer and Prostatic Diseases|August 21, 2013
Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancerM T Schweizer, J Lin, A Blackford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancerM A Rudek, W D Figg, V Dyer, et al.Pageof 2